Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Abbott Stories

2012-09-25 02:27:58

ABBOTT PARK, Ill., Sept. 25, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that Absorb(TM), the world's first drug eluting bioresorbable vascular scaffold (BVS), is now widely available across Europe and parts of Asia Pacific and Latin America. Absorb is a first-of-its-kind device for the treatment of coronary artery disease (CAD). It works by restoring blood flow to the heart similar to a metallic stent, but then dissolves into the body, leaving behind a treated...

2012-09-24 23:01:13

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates whose mission is to provide the public with free information regarding the potential dangers of using certain prescription medications, has a Web site URL of http://www.depakotebirthinjury.com. The CJF hereby reports that the Attorney General of Mississippi has announced that his office has reached a settlement agreement in the amount of $840,000.00 with Abbott Laboratories for its alleged...

2012-09-21 02:23:26

ABBOTT PARK, Ill., Sept. 21, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) today was again named one of the Top 20 Employers by the journal Science. Based on the views of working scientists, this prestigious annual survey identifies the most respected employers in the biotechnology and pharmaceutical industry. Abbott ranked No. 15 overall, receiving high marks for important, quality research, social responsibility and employee loyalty. The complete rankings are available online and in...

2012-09-18 06:25:34

ABBOTT PARK, Ill., Sept. 18, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) today was once again named one of the 100 Best Companies by Working Mother magazine. This is the twelfth consecutive year that Abbott has been included on the prestigious list, which recognizes companies for providing a family-friendly workplace. Additional information is in the October/November issue of Working Mother magazine and online at www.workingmother.com. "We are pleased to be recognized once again for...

2012-09-13 10:29:55

ABBOTT PARK, Ill., Sept. 13, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it was included on both the Dow Jones Sustainability World Index and North America Index for the eighth consecutive year. As a member of the Dow Jones Sustainability World Index, Abbott ranks among the top 300 of the 2,500 largest companies worldwide in corporate sustainability. The prestigious Dow Jones Sustainability Indexes (DJSI) recognize the leading companies in each industry sector for responsible...

2012-09-13 06:30:42

ABBOTT PARK, Ill., Sept. 13, 2012 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 51 cents per share. This marks the 355(th) consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 15, 2012, to shareholders of record at the close of business on Oct. 15, 2012. Abbott has increased its dividend payout for 40 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index,...

2012-09-12 02:29:23

NEW YORK, Sept. 12, 2012 /PRNewswire/ -- According to a recent national survey of more than 2,000 men, 52 percent say they usually see a doctor when something needs to be "fixed," and the majority (63 percent) report that prolonged, severe pain is the main "breaking point" for when they will visit the doctor - bleeding, vomiting or itching alone won't drive most men to see a doctor. Avoiding the doctor until a problem develops can be a risky approach to one's health and can have potentially...

2012-09-06 02:31:37

ABBOTT PARK, Ill., Sept. 6, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it has signed an agreement to collaborate with Astellas Pharma Global Development in a Phase 3 clinical trial for ASP0113 (TransVax(TM)), an investigational vaccine licensed from Vical Incorporated for preventing cytomegalovirus (CMV) reactivation in transplant patients. Under the agreement, Abbott's RealTime CMV assay, which is performed on the Abbott m2000 System and intended for investigational use...

2012-08-20 02:29:13

ABBOTT PARK, Ill., Aug. 20, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the XIENCE Xpedition(TM) Everolimus Eluting Coronary Stent System received CE Mark in Europe for the treatment of coronary artery disease. The company is launching the product immediately in CE Mark countries. XIENCE Xpedition features a new stent delivery system designed to optimize acute performance, particularly in challenging coronary anatomies. XIENCE Xpedition is supported by the...

2012-08-13 02:26:24

ABBOTT PARK, Ill., Aug. 13, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) has selected 40 undergraduate and graduate students living with cystic fibrosis (CF) to each receive a $2,500 CFCareForward Scholarship for use during the 2012-2013 academic year. Recipients were chosen based on their impressive academic merits, community involvement and creativity, and will now compete for two additional scholarships for a total award of $20,000 each - in honor of the 20(th) anniversary of the program....